Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
주식 순위 #25700
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
주가
$2.09
마지막 동기화: 2022-03-21
시가총액
$47.04M
변동 (1일)
-0.48%
변동 (1년)
0.00%
국가
US
거래 Recro Pharma, Inc. (REPH)

카테고리

Recro Pharma, Inc. (REPH)의 배당 수익률 기록
Recro Pharma, Inc. (주식 심볼: REPH)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Recro Pharma, Inc. (REPH)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)